Tumor necrosis factor in lung cancer: Complex roles in biology and resistance to treatment
2020 · Neoplasia · 82 citations
https://doi.org/10.1016/j.neo.2020.12.006
K
Ke Gong
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
54
Papers
1.6K
Citations
20
h-index
28
i10-index
Ke Gong is an academic researcher from Xinyang Normal University. The author has contributed to research in topics: Cytokine Signaling Pathways and Interactions & Glioma Diagnosis and Treatment & interferon and immune responses. The author has an h-index of 20, co-authored 46 publications.
ORCID: 0000-0002-8355-6770Papers by this author
worksAKR1B10 promotes breast cancer cell proliferation and migration via the PI3K/AKT/NF-κB signaling pathway
2021 · Cell & Bioscience · 81 citations
https://doi.org/10.1186/s13578-021-00677-3
Itraconazole Exerts Its Antitumor Effect in Esophageal Cancer By Suppressing the HER2/AKT Signaling Pathway
2021 · Molecular Cancer Therapeutics · 28 citations
https://doi.org/10.1158/1535-7163.mct-20-0638
Circ_FURIN knockdown assuages Testosterone-induced human ovarian granulosa-like tumor cell disorders by sponging miR-423-5p to reduce MTM1 expression in polycystic ovary syndrome
2022 · Reproductive Biology and Endocrinology · 25 citations
https://doi.org/10.1186/s12958-022-00891-9
The targetable nanoparticle BAF312@cRGD-CaP-NP represses tumor growth and angiogenesis by downregulating the S1PR1/P-STAT3/VEGFA axis in triple-negative breast cancer
2021 · Journal of Nanobiotechnology · 22 citations
https://doi.org/10.1186/s12951-021-00904-6
PLAC8 overexpression correlates with PD-L1 upregulation and acquired resistance to chemotherapies in gallbladder carcinoma
2019 · Biochemical and Biophysical Research Communications · 20 citations
https://doi.org/10.1016/j.bbrc.2019.06.121
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat